Julianne Flanagan to Stress Disorders, Post-Traumatic
This is a "connection" page, showing publications Julianne Flanagan has written about Stress Disorders, Post-Traumatic.
Connection Strength
4.152
-
A Preliminary Examination of Endogenous Peripheral Oxytocin in a Pilot Randomized Clinical Trial of Oxytocin-Enhanced Psychotherapy for Posttraumatic Stress Disorder. J Clin Psychopharmacol. 2020 Jul/Aug; 40(4):401-404.
Score: 0.334
-
Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial. Contemp Clin Trials. 2020 08; 95:106074.
Score: 0.333
-
Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder. Exp Clin Psychopharmacol. 2019 Feb; 27(1):45-54.
Score: 0.297
-
Behavioral Treatments for Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018; 39(2):181-192.
Score: 0.281
-
Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 03; 98:64-69.
Score: 0.280
-
The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218.
Score: 0.269
-
Concurrent Treatment of Substance Use and PTSD. Curr Psychiatry Rep. 2016 08; 18(8):70.
Score: 0.254
-
Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample. Am J Addict. 2016 06; 25(4):283-90.
Score: 0.251
-
A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans. J Clin Psychiatry. 2023 Mar 08; 84(2).
Score: 0.101
-
COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans. Contemp Clin Trials. 2023 03; 126:107084.
Score: 0.099
-
Putting the pieces together to understand anger in combat veterans and service members: Psychological and physical contributors. J Psychiatr Res. 2023 03; 159:57-65.
Score: 0.099
-
Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2022 04; 35(2):546-558.
Score: 0.092
-
STRONG STAR and the Consortium to Alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations. Contemp Clin Trials. 2021 11; 110:106583.
Score: 0.091
-
Effects of intranasal oxytocin on threat- and reward-related functional connectivity in men and women with and without childhood abuse-related PTSD. Psychiatry Res Neuroimaging. 2021 11 30; 317:111368.
Score: 0.090
-
Oxytocin, PTSD, and sexual abuse are associated with attention network intrinsic functional connectivity. Psychiatry Res Neuroimaging. 2021 10 30; 316:111345.
Score: 0.090
-
Craving Moderates the Effects of Intranasal Oxytocin on Anger in Response to Social Stress Among Veterans With Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorder. J Clin Psychopharmacol. 2021 Jul-Aug 01; 41(4):465-469.
Score: 0.089
-
Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment. J Ethn Subst Abuse. 2022 Jul-Sep; 21(3):1141-1164.
Score: 0.085
-
N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
Score: 0.081
-
Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 06 01; 199:70-75.
Score: 0.077
-
Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019 03; 90:369-377.
Score: 0.075
-
Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 03; 90:35-39.
Score: 0.074
-
Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans. Contemp Clin Trials. 2018 10; 73:8-15.
Score: 0.073
-
Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder. Exp Clin Psychopharmacol. 2018 08; 26(4):391-402.
Score: 0.073
-
Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes? Psychol Trauma. 2018 Nov; 10(6):662-665.
Score: 0.068
-
Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35.
Score: 0.067
-
Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity. J Consult Clin Psychol. 2017 Mar; 85(3):274-281.
Score: 0.066
-
Relations among social support, PTSD symptoms, and substance use in veterans. Psychol Addict Behav. 2016 Nov; 30(7):764-770.
Score: 0.065
-
PTSD and Daily Co-Occurrence of Drug and Alcohol Use Among Women Experiencing Intimate Partner Violence. J Dual Diagn. 2016; 12(1):36-42.
Score: 0.061
-
Smoking, posttraumatic stress disorder, and alcohol use disorders in a nationally representative sample of Australian men and women. Drug Alcohol Depend. 2015 Nov 01; 156:176-183.
Score: 0.060
-
Correlates of smoking status among women experiencing intimate partner violence: Substance use, posttraumatic stress, and coping. Am J Addict. 2015 Sep; 24(6):546-53.
Score: 0.059
-
Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23.
Score: 0.059
-
Anxiety and posttraumatic stress symptom pathways to substance use problems among community women experiencing intimate partner violence. Anxiety Stress Coping. 2015; 28(4):445-55.
Score: 0.056